Yongsheng Li (Chuan Li)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 30

Top Topics

Top Venues

Molecular biomedicine

Nature communications

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Jun He, Xianghua Zeng, Chunmei Wang, Enwen Wang, Yongsheng Li
Antibody-drug conjugates in cancer therapy: mechanisms and clinical studies. MedComm 5 (8) (2024)
Juan Lei, Lei Wu, Nan Zhang, Xudong Liu, Jiangang Zhang, Liwen Kuang, Jiongming Chen, Yijiao Chen, Dairong Li, Yongsheng Li
Carcinoembryonic antigen potentiates non-small cell lung cancer progression via PKA-PGC-1ɑ axis. Molecular biomedicine 5 (1) (2024)
Yan Zhao, Changchun Ma, Rongzhi Cai, Lijing Xin, Yongsheng Li, Lixin Ke, Wei Ye, Ting Ouyang, Jiahao Liang, Yuanfeng Chen, Yan Lin
NMR and MS reveal characteristic metabolome atlas and optimize esophageal squamous cell carcinoma early detection. Nature communications 15 (1) (2024)
Juan Lei, Lei Wu, Nan Zhang, Xudong Liu, Jiangang Zhang, Liwen Kuang, Jiongming Chen, Yijiao Chen, Dairong Li, Yongsheng Li
Carcinoembryonic antigen potentiates non-small cell lung cancer progression via PKA-PGC-1ɑ axis. Molecular biomedicine 5 (1) (2024)
Yang Chen, Yu Zhou, Ran Ren, Yu Chen, Juan Lei, Yongsheng Li
Harnessing lipid metabolism modulation for improved immunotherapy outcomes in lung adenocarcinoma. Journal for immunotherapy of cancer 12 (7) (2024)
Yan Zhao, Changchun Ma, Rongzhi Cai, Lijing Xin, Yongsheng Li, Lixin Ke, Wei Ye, Ting Ouyang, Jiahao Liang, Yuanfeng Chen, Yan Lin
NMR and MS reveal characteristic metabolome atlas and optimize esophageal squamous cell carcinoma early detection. Nature communications 15 (1) (2024)
Yan Zhao, Changchun Ma, Rongzhi Cai, Lijing Xin, Yongsheng Li, Lixin Ke, Wei Ye, Ting Ouyang, Jiahao Liang, Yuanfeng Chen, Yan Lin
NMR and MS reveal characteristic metabolome atlas and optimize esophageal squamous cell carcinoma early detection. Nature communications 15 (1) (2024)
Juan Lei, Lei Wu, Nan Zhang, Xudong Liu, Jiangang Zhang, Liwen Kuang, Jiongming Chen, Yijiao Chen, Dairong Li, Yongsheng Li
Carcinoembryonic antigen potentiates non-small cell lung cancer progression via PKA-PGC-1ɑ axis. Molecular biomedicine 5 (1) (2024)
Jingchun Wang, Qichao Xie, Lei Wu, Yu Zhou, Yanquan Xu, Yu Chen, Jiangang Zhang, Ran Ren, Shiming Yang, Yongsheng Li, Huakan Zhao
Stromal interaction molecule 1/microtubule-associated protein 1A/1B-light chain 3B complex induces metastasis of hepatocellular carcinoma by promoting autophagy. MedComm 5 (2) (2024)
Yan Zhang, Huakan Zhao, Yongsheng Li
Pleiotropic Regulation of PGC-1α in Tumor Initiation and Progression. Antioxidants & redox signaling (2024)
Yang Chen, Yu Zhou, Ran Ren, Yu Chen, Juan Lei, Yongsheng Li
Harnessing lipid metabolism modulation for improved immunotherapy outcomes in lung adenocarcinoma. Journal for immunotherapy of cancer 12 (7) (2024)
Shuai Yang, Lu Zheng, Lingling Li, Jiangang Zhang, Jingchun Wang, Huakan Zhao, Yu Chen, Xudong Liu, Hui Gan, Junying Chen, Mei Yan, Chuanyin He, Kai Li, Chen Ding, Yongsheng Li
Integrative multiomics analysis identifies molecular subtypes and potential targets of hepatocellular carcinoma. Clinical and translational medicine 14 (6) (2024)
Jun He, Xianghua Zeng, Chunmei Wang, Enwen Wang, Yongsheng Li
Antibody-drug conjugates in cancer therapy: mechanisms and clinical studies. MedComm 5 (8) (2024)
Shuai Yang, Lu Zheng, Lingling Li, Jiangang Zhang, Jingchun Wang, Huakan Zhao, Yu Chen, Xudong Liu, Hui Gan, Junying Chen, Mei Yan, Chuanyin He, Kai Li, Chen Ding, Yongsheng Li
Integrative multiomics analysis identifies molecular subtypes and potential targets of hepatocellular carcinoma. Clinical and translational medicine 14 (6) (2024)
Juan Lei, Lei Wu, Nan Zhang, Xudong Liu, Jiangang Zhang, Liwen Kuang, Jiongming Chen, Yijiao Chen, Dairong Li, Yongsheng Li
Carcinoembryonic antigen potentiates non-small cell lung cancer progression via PKA-PGC-1ɑ axis. Molecular biomedicine 5 (1) (2024)
Juan Lei, Lei Wu, Nan Zhang, Xudong Liu, Jiangang Zhang, Liwen Kuang, Jiongming Chen, Yijiao Chen, Dairong Li, Yongsheng Li
Carcinoembryonic antigen potentiates non-small cell lung cancer progression via PKA-PGC-1ɑ axis. Molecular biomedicine 5 (1) (2024)
Yang Chen, Yu Zhou, Ran Ren, Yu Chen, Juan Lei, Yongsheng Li
Harnessing lipid metabolism modulation for improved immunotherapy outcomes in lung adenocarcinoma. Journal for immunotherapy of cancer 12 (7) (2024)
Ran Ren, Yongsheng Li
STIM1 in tumor cell death: angel or devil? Cell death discovery 9 (1) (2023)
Lei Wu, Xudong Liu, Juan Lei, Nan Zhang, Huakan Zhao, Jiangang Zhang, Huan Deng, Yongsheng Li
Fibrinogen-like protein 2 promotes tumor immune suppression by regulating cholesterol metabolism in myeloid-derived suppressor cells. Journal for immunotherapy of cancer 11 (12) (2023)
Yi Hu, Qinglin Hu, Yongsheng Li, Li-Gong Lu, Zheng Xiang, Zhinan Yin, Dieter Kabelitz, Yangzhe Wu
γδ T cells: origin and fate, subsets, diseases and immunotherapy. Signal transduction and targeted therapy 8 (1) (2023)
Qi Zhang, Jian Li, Lin Shen, Yongsheng Li, Xicheng Wang
Opportunities and challenges of immunotherapy for dMMR/MSI-H colorectal cancer. Cancer biology & medicine (2023)
Jiangang Zhang, Yu Zhou, Juan Lei, Xudong Liu, Nan Zhang, Lei Wu, Yongsheng Li
Retention time prediction and MRM validation reinforce the biomarker identification of LC-MS based phospholipidomics. The Analyst (2023)
Yu Chen, Jingchun Wang, Yongsheng Li
Mitochondrial pyruvate carrier: a metabolic-epigenetic checkpoint orchestrating T cell differentiation. Signal transduction and targeted therapy 7 (1) (2022)
Shuai Yang, Jiangang Zhang, Yanquan Xu, Jingchun Wang, Huakan Zhao, Juan Lei, Yu Zhou, Yu Chen, Lei Wu, Mingyue Zhou, Lu Zheng, Xiaohui Ji, Yongsheng Li
OIT3 mediates macrophage polarization and facilitates hepatocellular carcinoma progression. Cancer immunology, immunotherapy : CII 71 (11) (2022)
Huakan Zhao, Yongsheng Li
Cancer metabolism and intervention therapy. Molecular biomedicine 2 (1) (2021)
Qi Zhang, Guifang Yan, Juan Lei, Yu Chen, Ting Wang, Juan Gong, Yong Zhou, Huakan Zhao, Hao Chen, Yu Zhou, Lei Wu, Jiangang Zhang, Xiao Zhang, Jingchun Wang, Yongsheng Li
The SP1-12LOX axis promotes chemoresistance and metastasis of ovarian cancer. Molecular medicine (Cambridge, Mass.) 26 (1) (2020)
Lei Wu, Xiao Zhang, Lu Zheng, Huakan Zhao, Guifang Yan, Qi Zhang, Yu Zhou, Juan Lei, Jiangang Zhang, Jingchun Wang, Rong Xin, Lu Jiang, Jin Peng, Qian Chen, Sin Man Lam, Guanghou Shui, Hongming Miao, Yongsheng Li
RIPK3 Orchestrates Fatty Acid Metabolism in Tumor-Associated Macrophages and Hepatocarcinogenesis. Cancer immunology research 8 (5) (2020)
Shenglan Shang, Xinran Ji, Lili Zhang, Jun Chen, Yongsheng Li, Rongchen Shi, Wei Xiang, Xia Kang, Dapeng Zhang, Fan Yang, Rongyang Dai, Peng Chen, Shan Chen, Yongchuan Chen, Hongming Miao
Macrophage ABHD5 Suppresses NFκB-Dependent Matrix Metalloproteinase Expression and Cancer Metastasis. Cancer research 79 (21) (2019)
Yu Zhou, Juan Lei, Qichao Xie, Lei Wu, Shengwei Jin, Bo Guo, Xiang Wang, Guifang Yan, Qi Zhang, Huakan Zhao, Jiangang Zhang, Xiao Zhang, Jingchun Wang, Jiaqi Gu, Xiaoli Liu, Duyun Ye, Hongming Miao, Charles Nicholas Serhan, Yongsheng Li
Fibrinogen-like protein 2 controls sepsis catabasis by interacting with resolvin Dp5. Science advances 5 (11) (2019)
Wei Xiang, Rongchen Shi, Xia Kang, Xuan Zhang, Peng Chen, Lili Zhang, Along Hou, Rui Wang, Yuanyin Zhao, Kun Zhao, Yingzhe Liu, Yue Ma, Huan Luo, Shenglan Shang, Jinyu Zhang, Fengtian He, Songtao Yu, Lixia Gan, Chunmeng Shi, Yongsheng Li, Wei Yang, Houjie Liang, Hongming Miao
Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression. Nature communications 9 (1) (2018)